Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2006
07/13/2006WO2006073967A1 Piperidine derivatives as prodrugs of potassium channel inhibitors
07/13/2006WO2006073779A1 Novel omeprazole forms and related methods
07/13/2006WO2006073367A1 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver x receptor modulators
07/13/2006WO2006073361A1 Novel pyridine compounds
07/13/2006WO2006073167A1 Pyrrolidine derivatives
07/13/2006WO2006072736A1 N- (heteroaryl) -1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands
07/13/2006WO2006072426A1 Alkinyl-oxypyrimidine used in the form of pesticides
07/13/2006WO2006072353A1 Azetidine-substituted pyrazolines as par-1 antagonists
07/13/2006WO2006039718A3 Aryl nitrogen-containing bicyclic compounds and their use as kinase inhibitors
07/13/2006WO2006031764A3 Processes for prepating n-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and intermediates
07/13/2006WO2006031513A3 Aryl spirolactam cgrp receptor antagonists
07/13/2006WO2006030977A3 Imidazole derivatives as large conductance calcium-activated k channel openers
07/13/2006WO2006021833A3 Bisbenzamidines for the treatment of pneumonia
07/13/2006WO2006021457A3 Pyrimidine derivatives
07/13/2006WO2006002088A3 Amino-quinazoline derivatives as antitumor agents
07/13/2006WO2005095379B1 Crystalline methanesulfonic acid addition salts of imatinib
07/13/2006WO2005090302A3 Palladium catalyzed indolization of 2-bromo or chloroanilines
07/13/2006WO2004096139A3 Aza spiro alkane derivatives as inhibitors of metalloproteases
07/13/2006WO2004065367A8 Viral polymerase inhibitors
07/13/2006US20060155140 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors
07/13/2006US20060155129 etherification of 4-(6'-chloro-5'-methylpyrimidin-4'-yloxypiperidine)-1-carboxylic acid isopropyl ester with 2-Fluoro-4-methanesulfonylphenol, to form 4-[6-(2-fluoro-4-methanesulfonyl-phenoxy)-5-methyl-pyrimidin-4-yloxy]-piperidine-1-carboxylic Acid Isopropyl Ester; antidiabetic agents
07/13/2006US20060155128 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
07/13/2006US20060154969 Adenosine receptor selective modulators
07/13/2006US20060154967 e.g. [2-methyl-5-trifluoromethyl-2H-1,2,3-triazole-4-carboxylic acid methyl ester; fungicide; against the phytopathogenic fungi: Fungi imperfecti (Botrytis, Pyricularia, Helminthosporium), Basidiomycetes (Rhizoctonia, Hemileia), Ascomycetes classes (Venturia, Erysiphe), Oomycetes classes (Phytophthora)
07/13/2006US20060154964 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
07/13/2006US20060154951 Quaternary antimuscarinic compounds for the treatment of bladder diseases
07/13/2006US20060154949 Arylindenopyridines and related therapeutic and prophylactic methods
07/13/2006US20060154931 phosphodiesterase (PDE) inhibitors; 2-[4-(4-Pyridin-4-yl-2H-pyrazol-3-yl)-phenoxymethyl]-quinoline; for treating central nervous system disorders, neurodegenerative and psychiatric disorders
07/13/2006US20060154913 Drugs for treatment of respiratory syncytial virus and salt formation
07/13/2006US20060154872 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting
07/13/2006US20060154105 Nitrogenous heterocyclic derivative and organic elecrtroluminescent element employing the same
07/13/2006DE102005000747A1 Substituierte Pyrimidine Substituted pyrimidines
07/13/2006CA2605214A1 Benzylamine derivatives as cetp inhibitors
07/13/2006CA2596393A1 4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase for the treatment of anxiety, pain and other conditions
07/13/2006CA2594418A1 N-(heteroaryl)-1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands
07/13/2006CA2594255A1 Novel pyridine compounds
07/13/2006CA2594114A1 Synthesis of ccr5 receptor antagonists
07/13/2006CA2594109A1 Preparation of pharmaceutical salts of piperazine compounds
07/13/2006CA2594106A1 Preparation of ketone amides
07/13/2006CA2593266A1 Aryl piperazine derivatives for the treatment of neuropsychiatric disorders
07/13/2006CA2593098A1 Sulfonyl pyrrolidines, method for producing the same and their use as drugs
07/13/2006CA2593044A1 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof
07/13/2006CA2592900A1 Nitrogen containing bicyclic compounds and therapeutical use thereof
07/13/2006CA2590110A1 Kinase modulators and method of use
07/13/2006CA2587919A1 Salts of n-[2-({3r)-1-[trans-4-hydroxy-4-(6-methoxypyridin-3-yl)-cyclohexyl]pyrrolidine-3-yl}amino)-2-oxoethyl]-3-(trifluoromethyl)benzamide
07/12/2006EP1679313A2 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
07/12/2006EP1679310A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring
07/12/2006EP1679308A1 Novel indazole derivative
07/12/2006EP1679296A1 Ether derivative
07/12/2006EP1679069A1 Novel piperidine derivative
07/12/2006EP1678173A2 4-heterobicyclylamino-substituted quinazolines and analogues thereof as capsaicin-antagonists
07/12/2006EP1678172A2 Azabicyclic compounds for relieving pain and treating central nervous system disorders
07/12/2006EP1678167A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
07/12/2006EP1678164A1 Substituted pyrazinone compounds for the treatment of inflammation
07/12/2006EP1678163A1 Novel imidazole derivatives and their use as pharmaceutical agents
07/12/2006EP1678162A1 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
07/12/2006EP1678161A2 Thioether-substituted benzamides as inhibitors of factor xa
07/12/2006EP1678160A1 Pyrazine derivatives and pharmaceutical use thereof
07/12/2006EP1678149A2 4-amino(aza)quinoline derivatives as capsaicin receptor agonists
07/12/2006EP1678147A1 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
07/12/2006EP1678146A1 Pyrimidine compounds for the treatment of inflammation
07/12/2006EP1678145A2 Benzimidazoles useful as modulators of ion channels
07/12/2006EP1678144A1 1,5,7-TRISUBSTITUTED BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABA-a RECEPTOR COMPLEX
07/12/2006EP1678138A1 Pyridine compounds as inhibitors of dipeptidyl peptidase iv
07/12/2006EP1678137A1 Compositions and methods for viral inhibition
07/12/2006EP1678135A1 Process for the preparation of n-amino substituted heterocyclic compounds
07/12/2006EP1678121A2 Tao kinase modulators and methods of use
07/12/2006EP1677799A1 Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain
07/12/2006EP1677786A1 5-substituted 2-(phenylmethyl)thio-4-phenyl-4h-1,2,4-triazole derivatives and related compounds as gaba-agonists for the treatment of urinary incontinence and related diseases
07/12/2006EP1677783A2 Fibrinogen receptor antagonists and their use
07/12/2006EP1441718B1 Use of carbinols for the treatment of neuropathic dysfunction
07/12/2006EP1103547B1 Formazan metal complex
07/12/2006EP1076648B1 Method for the catalytic production of substituted dipyridyl derivatives
07/12/2006EP1025846B1 Aqueous liquid preparations
07/12/2006CN1802376A Cgrp受体拮抗剂 Cgrp receptor antagonists
07/12/2006CN1802369A Cgrp受体拮抗剂 Cgrp receptor antagonists
07/12/2006CN1802368A Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists
07/12/2006CN1802367A Imidazole derivatives as glutmate receptor antagonists
07/12/2006CN1802354A Tetrahydrocarbazole derivatives and their pharmaceutical use
07/12/2006CN1802351A Substituted 3-alkyl and 3-alkenyl azetidine derivatives
07/12/2006CN1802187A Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
07/12/2006CN1802159A 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
07/12/2006CN1802156A Aminoquinoline compounds
07/12/2006CN1800178A Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof
07/12/2006CN1800177A Reduced aminate of geniposide huperzine A and its preparation method and uses
07/12/2006CN1800163A Dissymmetrical diazo compounds comprising 2-pyridinium group and a cationic or non-cationic linker, compositions comprising them, method for coloring, and device
07/12/2006CN1263753C Method for synthetizing orixine and RU-19110 intermediate
07/12/2006CN1263746C Pyridazinone derivatives
07/12/2006CN1263745C Aryl fused azapolycyclic compounds
07/12/2006CN1263733C Substituted phenyl derivatives, their preparation and use
07/11/2006US7074935 Multistage process with acylation of amine as anesthetics
07/11/2006US7074932 Preparation of quinoline-substituted carbonate and carbamate derivatives
07/11/2006US7074816 Gout; xanthine oxidase inhibitors; reacting iminoether or an aromatic nitrile with hydrazide
07/11/2006US7074813 Antiproliferation agent; antiumor, anticancer agents
07/11/2006US7074811 for use in the treatment and/or prophylaxis of diabetes mellitus
07/11/2006US7074810 Triazolone and triazolethione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme
07/11/2006US7074809 Exhibiting an activity at metabotropic glutamate receptors (mGluRs), especially at the mGluR5 receptor
07/11/2006US7074808 4-(Phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders
07/11/2006US7074806 Antiinflammatory agents, antiallergens, antiproliferative agents, immunosuppressants, antidiabetic agents, cardiovascular disorders
07/11/2006US7074805 Especially isoquinolin-5-ylurea derivatives; treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.